Bedtime snacking with delayed insulin delivery increases risk of overnight hyperglycemia in hospitalized diabetes patients: Study

The In-Fi study, compared Fiasp with insulin aspart (Novolog) in inpatients with type 2 diabetes, was the subject of a post hoc analysis by researchers. The Dexcom G6 PRO continuous glucose monitoring (CGM) device was used to measure the glucose results. A total of 122 randomized participants who finished the primary trial protocol (which involved wearing a CGM for at least 4 meals) had their CGM and insulin delivery data examined. This study assesses the effects of bedtime eating and postponed insulin injection on glucose regulation.

Insulin boluses given before meals (n = 149) had a 4-hour postprandial time in range (TIR70–180) of 48%, while those given more than 5 minutes after a meal had a TIR70–180 of 24%. When controlling for bedtime sensor glucose, eating between 9 p.m. and 12 a.m. was linked to a considerably lower overnight (9 p.m. and 6 a.m.) TIR70–180 and a significantly higher fasting glucose the following morning.

After controlling for initial bedtime sensor glucose, bedtime eating was linked to greater overnight glucose percentage coefficient of variation and higher overnight glucose standard deviation. Overall, one of the main cause of post-meal and nocturnal hyperglycemia in hospitalized patients is the delayed administration of insulin during meals and the consumption of insulin-free snacks before bed. 

Reference:

Alexanian, S. M., Cheney, M. C., Bello Ramos, J. C., Spartano, N. L., Wolpert, H. A., & Steenkamp, D. W. (2025). Impact of meal insulin bolus timing and bedtime snacking on continuous glucose monitoring-derived glycemic metrics in hospitalized inpatients. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2025.0027